A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is
We have tested the ability of various glycosaminoglycans to increase the rate of inhibition of thrombin by heparin cofactor II (HCII) and by antithrombin III (ATIII) isolated from human plasma. Heparin, dermatan sulfate, and heparan sulfate from bovine liver (in order of decreasing activity) activated HCII. In contrast, only heparin and bovine liver heparan sulfate activated ATIII, whereas dermatan sulfate was inactive at concentrations less than or equal to 1 mg/ml. Heparan sulfate from humanpmid:6687888 fatcat:z76shkcksvgf3jrgm7y3mvifjm